What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary areas of study are Internal medicine, Gastroenterology, Immunology, Hepatitis C and Hepatitis C virus.
His Internal medicine study incorporates themes from Ribavirin and Surgery.
His Ribavirin research includes themes of Regimen and Adverse effect.
His work investigates the relationship between Gastroenterology and topics such as Voxilaprevir that intersect with problems in Elbasvir.
His work in Hepatitis C covers topics such as Randomized controlled trial which are related to areas like Not evaluated and Ascites.
His Hepatitis C virus research is multidisciplinary, incorporating elements of Prevalence, Serology, Antigen and Hemodialysis.
His most cited work include:
- Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. (5906 citations)
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection (2132 citations)
- Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection (1569 citations)
What are the main themes of his work throughout his whole career to date?
K. Rajender Reddy mostly deals with Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C and Liver transplantation.
His Internal medicine research includes elements of Ribavirin, Hepatitis C virus, Surgery and Immunology.
His research integrates issues of Regimen and Adverse effect in his study of Ribavirin.
His Gastroenterology study combines topics from a wide range of disciplines, such as Hepatitis B, Hepatocellular carcinoma, Placebo and Viral load.
His study in Cirrhosis is interdisciplinary in nature, drawing from both Creatinine, Ascites, Hepatology and Cohort.
As part of his studies on Hepatitis C, K. Rajender Reddy frequently links adjacent subjects like Randomized controlled trial.
He most often published in these fields:
- Internal medicine (69.32%)
- Gastroenterology (44.81%)
- Cirrhosis (27.15%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (69.32%)
- Cirrhosis (27.15%)
- Gastroenterology (44.81%)
In recent papers he was focusing on the following fields of study:
K. Rajender Reddy spends much of his time researching Internal medicine, Cirrhosis, Gastroenterology, Liver disease and Liver transplantation.
The concepts of his Internal medicine study are interwoven with issues in Hepatitis C virus and Sofosbuvir.
His biological study spans a wide range of topics, including Prospective cohort study and Intensive care unit.
The study incorporates disciplines such as Creatinine, Ribavirin, Viral load and Steatohepatitis in addition to Gastroenterology.
His Ribavirin research focuses on Adverse effect and how it connects with Placebo.
His research in Liver transplantation tackles topics such as Kidney disease which are related to areas like Diabetes mellitus.
Between 2017 and 2021, his most popular works were:
- Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. (270 citations)
- Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement. (163 citations)
- Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection (96 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Internal medicine, Cirrhosis, Gastroenterology, Liver disease and Hepatitis C are his primary areas of study.
Internal medicine and Sofosbuvir are frequently intertwined in his study.
His work carried out in the field of Sofosbuvir brings together such families of science as Ledipasvir, Pibrentasvir, Voxilaprevir and Glecaprevir.
His Cirrhosis study integrates concerns from other disciplines, such as Prospective cohort study, Hepatology and Intensive care unit.
His Gastroenterology study combines topics in areas such as Kidney disease, Renal function, Vein, Vasoconstriction and Ribavirin.
He interconnects Portal hypertension, Portal venous pressure, Blood pressure, Dialysis and Model for End-Stage Liver Disease in the investigation of issues within Liver disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
